Landscapes / Companies
Aptabio Therapeutics, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
3
in active trials · 4 in all
Trials
3 active
6 since 2021
Drugs3
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 2 | 30 Jun 2027Phase 2 trial completes | |||
| Next date | 30 Jun 2027 · Phase 2 trial completes | ||||
| Also tested for | Diabetic Kidney Disease (DKD) | ||||
| Open drug page | |||||
— |
Phase 1 | Nov 2027Phase 1 trial completes | |||
| Next date | Nov 2027 · Phase 1 trial completes | ||||
| Also tested for | Age Related Macular Degeneration (ARMD), AMD - Age-Related Macular Degeneration | ||||
| Open drug page | |||||
— |
Phase 1 | Oct 2028Phase 1 trial completes | |||
| Next date | Oct 2028 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Cancer, Advanced Solid Tumor (Phase 1) | ||||
| Open drug page | |||||
About
- No active trial
- APX-115
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021